Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Conditions: BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast CancerInterventions: Dietary Supplement: soy isoflavones; Other: placebo; Other: questionnaire administration; Procedure: magnetic resonance imaging; Procedure: biopsy; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Procedure: mammographySponsors: University of Southern California; National Cancer Institute (NCI); California Breast Cancer Research ProgramActive, not recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Carcinoma | Mammography | Nutrition | Research | Soy isoflavones | Women